175 related articles for article (PubMed ID: 25895305)
1. [Expression and clinical significance of Ki67 and calcitonin in medullary thyroid carcinoma].
Feng J; Wang J
Lin Chuang Er Bi Yan Hou Tou Jing Wai Ke Za Zhi; 2014 Dec; 28(24):1921-4. PubMed ID: 25895305
[TBL] [Abstract][Full Text] [Related]
2. Expression of Prox1 in Medullary Thyroid Carcinoma Is Associated with Chromogranin A and Calcitonin Expression and with Ki67 Proliferative Index, but Not with Prognosis.
Saglietti C; La Rosa S; Sykiotis GP; Letovanec I; Bulliard JL; Piana S; Mermod M; Petrova T; Uccella S; Sessa F; Bongiovanni M
Endocr Pathol; 2019 Jun; 30(2):138-145. PubMed ID: 31001799
[TBL] [Abstract][Full Text] [Related]
3. Clinical and pathological analysis of 19 cases of medullary thyroid carcinoma without an increase in calcitonin.
Zhou Q; Yue S; Cheng Y; Jin J; Xu H
Exp Toxicol Pathol; 2017 Oct; 69(8):575-579. PubMed ID: 28552629
[TBL] [Abstract][Full Text] [Related]
4. Mixed medullary-papillary carcinoma of the thyroid: report of two cases and review of the literature.
Gurkan E; Gurbuz Y; Tarkun I; Canturk Z; Cetinarslan B
Indian J Pathol Microbiol; 2014; 57(4):598-602. PubMed ID: 25308015
[TBL] [Abstract][Full Text] [Related]
5. Ultrasonographic Features of Medullary Thyroid Carcinoma: Do they Correlate with Pre and PostOperative Calcitonin Levels?
Cho KE; Gweon HM; Park AY; Yoo MR; Kim J; Youk JH; Park YM; Son EJ
Asian Pac J Cancer Prev; 2016; 17(7):3357-62. PubMed ID: 27509975
[TBL] [Abstract][Full Text] [Related]
6. Lymph node metastases and elevated postoperative calcitonin: Predictors of poor survival in medullary thyroid carcinoma.
Siironen P; Hagström J; Mäenpää HO; Louhimo J; Arola J; Haglund C
Acta Oncol; 2016; 55(3):357-64. PubMed ID: 26339947
[TBL] [Abstract][Full Text] [Related]
7. Reduced Retinoblastoma Protein Expression Is Associated with Decreased Patient Survival in Medullary Thyroid Cancer.
Valenciaga A; Grubbs EG; Porter K; Wakely PE; Williams MD; Cote GJ; Vasko VV; Saji M; Ringel MD
Thyroid; 2017 Dec; 27(12):1523-1533. PubMed ID: 29105562
[TBL] [Abstract][Full Text] [Related]
8. C-cell-derived calcitonin-free neuroendocrine carcinoma of the thyroid: the diagnostic importance of CGRP immunoreactivity.
Nakazawa T; Cameselle-Teijeiro J; Vinagre J; Soares P; Rousseau E; Eloy C; Sobrinho-Simões M
Int J Surg Pathol; 2014 Sep; 22(6):530-5. PubMed ID: 24599901
[TBL] [Abstract][Full Text] [Related]
9. [Correlation analysis of clock genes and MEN2 medullary thyroid carcinoma].
Mou YK; Ren C; Li YM; Yu GH; Zheng GB; Song H; Lu CX; Tian RX; Song XC
Zhonghua Er Bi Yan Hou Tou Jing Wai Ke Za Zhi; 2022 Sep; 57(9):1079-1086. PubMed ID: 36177562
[No Abstract] [Full Text] [Related]
10. [Cervical lymph node metastasis in medullary thyroid carcinoma].
Yan D; Zhang B; Li Z; Wu Y; Liu S; Liu W; Xu Z; Tang P
Zhonghua Er Bi Yan Hou Tou Jing Wai Ke Za Zhi; 2015 Apr; 50(4):290-4. PubMed ID: 26081082
[TBL] [Abstract][Full Text] [Related]
11. Combined RET and Ki-67 assessment in sporadic medullary thyroid carcinoma: a useful tool for patient risk stratification.
Mian C; Pennelli G; Barollo S; Cavedon E; Nacamulli D; Vianello F; Negro I; Pozza G; Boschin IM; Pelizzo MR; Rugge M; Mantero F; Girelli ME; Opocher G
Eur J Endocrinol; 2011 Jun; 164(6):971-6. PubMed ID: 21422198
[TBL] [Abstract][Full Text] [Related]
12. Prevalence and clinical spectrum of nonsecretory medullary thyroid carcinoma in a series of 839 patients with sporadic medullary thyroid carcinoma.
Frank-Raue K; Machens A; Leidig-Bruckner G; Rondot S; Haag C; Schulze E; Lorenz A; Kreissl MC; Dralle H; Raue F; Schmid KW
Thyroid; 2013 Mar; 23(3):294-300. PubMed ID: 22946486
[TBL] [Abstract][Full Text] [Related]
13. International Medullary Thyroid Carcinoma Grading System: A Validated Grading System for Medullary Thyroid Carcinoma.
Xu B; Fuchs TL; Ahmadi S; Alghamdi M; Alzumaili B; Bani MA; Baudin E; Chou A; De Leo A; Fagin JA; Ganly I; Glover A; Hartl D; Kanaan C; Khneisser P; Najdawi F; Nigam A; Papachristos A; Repaci A; Spanheimer PM; Solaroli E; Untch BR; Barletta JA; Tallini G; Al Ghuzlan A; Gill AJ; Ghossein RA
J Clin Oncol; 2022 Jan; 40(1):96-104. PubMed ID: 34731032
[TBL] [Abstract][Full Text] [Related]
14. Tumor Grade Predicts for Calcitonin Doubling Times and Disease-Specific Outcomes After Resection of Medullary Thyroid Carcinoma.
Nigam A; Xu B; Spanheimer PM; Ganly I; Tuttle RM; Wong RJ; Shaha AR; Ghossein RA; Untch BR
Thyroid; 2022 Oct; 32(10):1193-1200. PubMed ID: 35950622
[No Abstract] [Full Text] [Related]
15. Expression and role of estrogen receptor alpha and beta in medullary thyroid carcinoma: different roles in cancer growth and apoptosis.
Cho MA; Lee MK; Nam KH; Chung WY; Park CS; Lee JH; Noh T; Yang WI; Rhee Y; Lim SK; Lee HC; Lee EJ
J Endocrinol; 2007 Nov; 195(2):255-63. PubMed ID: 17951536
[TBL] [Abstract][Full Text] [Related]
16. Surgery for lymph node metastases of medullary thyroid carcinoma: A review.
Jin LX; Moley JF
Cancer; 2016 Feb; 122(3):358-66. PubMed ID: 26539937
[TBL] [Abstract][Full Text] [Related]
17. Expression of calcitonin gene-related peptide in medullary thyroid cancer.
Pacini F; Fugazzola L; Basolo F; Elisei R; Pinchera A
J Endocrinol Invest; 1992; 15(7):539-42. PubMed ID: 1447491
[TBL] [Abstract][Full Text] [Related]
18. Oncologic outcomes of calcitonin-negative medullary thyroid carcinoma.
Yue W; Zhang Y
Front Endocrinol (Lausanne); 2022; 13():1025629. PubMed ID: 36506082
[TBL] [Abstract][Full Text] [Related]
19. Procalcitonin as a postoperative marker in the follow-up of patients affected by medullary thyroid carcinoma.
Trimboli P; Lauretta R; Barnabei A; Valabrega S; Romanelli F; Giovanella L; Appetecchia M
Int J Biol Markers; 2018 May; 33(2):156-160. PubMed ID: 29707993
[TBL] [Abstract][Full Text] [Related]
20. [Neuroendocrine carcinoma of the larynx with secretion of calcitonin: primary tumor or metastasis of the medullary thyroid carcinoma?].
Vildé F; Arkwright S; Paoli C; Périchon I; Le Charpentier Y; Le Bodic MF
Ann Pathol; 1996; 16(2):104-7. PubMed ID: 8767676
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]